Glucose cannot pass through cell membranes on its own. It needs specialized transporter proteins embedded in the membrane to carry it inside. Your body uses two main systems for this: passive transporters (called GLUTs) that shuttle glucose down its concentration gradient without energy, and active co-transporters (called SGLTs) that pump glucose against its gradient by pairing it with sodium ions. Which system a cell uses depends on where it sits in the body and what job it needs to do.
Facilitated Diffusion Through GLUT Transporters
Most cells take in glucose through a family of proteins known as GLUT transporters. These work by facilitated diffusion, meaning they move glucose from where it’s more concentrated to where it’s less concentrated, no energy required. The transporter sits in the cell membrane and uses an “alternating access” mechanism: it opens toward the outside of the cell, glucose binds to a site inside the protein channel, the protein shifts shape, and then it opens toward the inside to release glucose into the cell. Recent molecular simulations show this process is controlled by a gate made up of residues on four of the protein’s twelve membrane-spanning segments. When glucose is present, the gate opens wide enough to let the sugar molecule pass through.
There are at least five well-characterized GLUT proteins, each tuned for a different tissue and situation:
- GLUT1 is found in nearly every tissue and handles baseline glucose uptake. It also moves glucose across barriers like the blood-brain barrier. Its affinity for glucose (around 3 to 10 mM, depending on measurement conditions) means it works efficiently at normal blood sugar levels.
- GLUT2 sits in the liver, pancreas, kidneys, and small intestine. It has a much lower affinity for glucose (about 17 mM), which means it only ramps up transport when glucose levels are high. This makes it ideal for sensing post-meal sugar surges.
- GLUT3 is the primary transporter in the brain. It has the highest affinity of the group (around 1.4 to 2.6 mM), so neurons can pull in glucose even when concentrations are relatively low. That tight grip ensures a steady fuel supply for the brain.
- GLUT4 is the insulin-responsive transporter found in muscle, fat, and heart tissue. It stays stored inside the cell until insulin signals it to move to the surface.
- GLUT5 is specialized for fructose, not glucose. It’s most active in the small intestine, where it absorbs fructose from food.
The differences in affinity matter practically. A lower number means the transporter grabs glucose more eagerly. GLUT3 in the brain has roughly threefold higher affinity than GLUT1, even though the two proteins have structurally identical glucose-binding sites. The difference comes from subtle variations in how the rest of the protein moves and regulates the gate’s opening.
How Insulin Opens the Door in Muscle and Fat
In muscle and fat cells, glucose can’t get in efficiently without insulin’s help. These cells keep their GLUT4 transporters tucked away in storage compartments inside the cell. When you eat and blood sugar rises, the pancreas releases insulin. Insulin binds to receptors on the cell surface and triggers a chain of signaling events inside the cell. The end result: those GLUT4 storage compartments travel to the cell membrane and fuse with it, suddenly populating the surface with transporters ready to pull glucose in.
Once insulin levels drop, the transporters get recycled back inside the cell, and glucose uptake slows. This is the mechanism that breaks down in type 2 diabetes. The cells become less responsive to insulin’s signal, so fewer GLUT4 transporters reach the surface, and glucose builds up in the bloodstream instead of entering cells.
Exercise Bypasses Insulin
Physical activity drives glucose into muscle cells through a completely separate pathway that doesn’t require insulin. For years, researchers attributed this to an energy-sensing enzyme activated during exercise. But studies in mice engineered to lack that enzyme showed completely normal glucose uptake during exercise, proving it isn’t required. Current research points instead to other signals generated by muscle contraction, including nitric oxide and reactive oxygen species, as likely triggers for moving GLUT4 to the cell surface. This is why exercise lowers blood sugar even in people whose cells have become insulin resistant.
Active Transport in the Gut and Kidneys
Some tissues need to move glucose against its concentration gradient, pulling it from a low-concentration space into cells that already have plenty. This happens in two key places: the lining of the small intestine (absorbing glucose from digested food) and the kidneys (reclaiming glucose from urine before it’s lost).
These tissues use SGLT transporters, which work differently from GLUTs. SGLTs are co-transporters. They harness the flow of sodium ions moving down their own concentration gradient to drag glucose along for the ride. The sodium gradient itself is maintained by a separate pump that uses ATP, so while SGLTs don’t burn energy directly, they depend on an energy-consuming system working in the background. SGLT2, found in the kidney’s proximal tubules, is responsible for reclaiming the majority of glucose that gets filtered out of the blood. This is high-capacity work, handling large volumes of glucose every day.
This kidney mechanism has become a drug target. A class of diabetes medications works by blocking SGLT2 in the kidney, preventing it from reabsorbing glucose. The result is that excess glucose leaves the body through urine instead of being sent back into the bloodstream. These drugs reduce glucose reabsorption by 30% to 60% and typically lower long-term blood sugar markers by 0.5% to 1.0%.
Glucose Entry Into the Brain
The brain consumes enormous amounts of glucose but is protected by the blood-brain barrier, a tightly sealed layer of cells lining blood vessels in the brain. Glucose crosses this barrier through GLUT1 transporters expressed on both sides of those endothelial cells: the side facing the blood and the side facing brain tissue.
Interestingly, the GLUT1 proteins on these two sides are not identical in behavior. On the blood-facing side, GLUT1 tends to carry multiple chemical modifications (phosphorylations) that alter its shape and transport properties. On the brain-facing side, the transporter is mostly unmodified. This asymmetry may allow the brain to fine-tune glucose delivery quickly in response to local demand, adjusting transport rates faster than would be possible by simply adding or removing transporters from the membrane.
Under normal conditions, GLUT1 transport is not the bottleneck for brain metabolism. The brain gets enough glucose. But during seizures, low blood sugar, or reduced oxygen supply, transport across the barrier can become the limiting factor, potentially starving neurons of fuel.
What Can Block Glucose From Entering Cells
Several compounds can jam GLUT transporters and prevent glucose uptake. Cytochalasin B, a fungal toxin used widely in lab research, is one of the most potent. It binds to the inward-facing side of GLUT1 with an IC50 of about 0.11 micromolar, meaning very small amounts can shut down transport. It works by wedging into the same pocket where glucose would normally sit as it exits toward the cell interior, physically blocking the transporter’s cycle.
In the body, glucose transport can be impaired by less exotic problems. Chronic high insulin levels can reduce the number of transporters cells place on their surface. Inflammation and certain metabolic conditions alter how cells respond to insulin signaling, leaving GLUT4 stranded inside the cell. Even the brain’s GLUT1 levels can decline in certain neurological conditions, reducing the brain’s access to its primary fuel.